Medicine and Dentistry
Pregnancy Termination
100%
Cross Sectional Study
40%
Clinician
31%
Conscience
28%
Meta-Analysis
27%
Systematic Review
27%
Prevalence
23%
Obstetrics
18%
Perinatology
15%
Attitude
15%
Antral Follicle
13%
Estrogen Therapy
13%
Case-Control Study
13%
Leiomyomatosis
13%
Lutetium 177
13%
Radioisotope Therapy
13%
Yttrium 90
13%
Androgen
13%
Overactive Bladder
13%
Neuromodulation
13%
Patient Satisfaction
13%
Postmenopause
13%
Vagina Atrophy
13%
Morphometrics
13%
Patient with Epilepsy
13%
Nerve Cell Differentiation
13%
Transobturator Tape Procedure
13%
Mood Disorder
13%
Patient Care
13%
Postpartum Depression
13%
Ultrasound Therapy
13%
Lower Urinary Tract Symptom
13%
Cardiovascular Disease
13%
Vitamin D
13%
Depression
13%
Cardiomyopathy
13%
Nuchal Translucency Measurement
13%
Fear of Childbirth
13%
Quality of Life
13%
Rhesus D Antibody
13%
Cholelithiasis
13%
Immunoglobulin
10%
Disease
9%
Radionuclide Therapy
9%
Peptide Receptor
9%
Lifespan
9%
Medical Record
7%
Neuroendocrine Tumor
6%
Contraceptive Behavior
6%
Assisted Reproduction
6%
Population Size
6%
Tertiary Care
6%
Burnout
6%
Fertilization
6%
Low Birth Weight
6%
Medicine
6%
Fetal Disease
6%
Sensitization
5%
Keyphrases
Antral Follicle Count
13%
Radioisotope Therapy
13%
Yttrium-90
13%
Disseminated Peritoneal Leiomyomatosis
13%
Lutetium-177 (177Lu)
13%
Maternal Cortisol
13%
Postpartum Depressive Disorder
13%
Follicular Growth
13%
Psychosocial Profile
13%
Overactive Bladder Symptom Score (OABSS)
13%
Uterine Artery Pseudoaneurysm
13%
Transarterial Embolization
13%
Ultrasonographic Imaging
13%
Italian Students
13%
Midwifery Students
13%
Sex Life
13%
Transobturator Tape Procedure
13%
Midurethral Sling
13%
Postpartum Mental Health
13%
Retrospective Comparative Study
13%
Adverse Complications
13%
Psychological Risk Factors
13%
Legal Awareness
13%
Social Support Satisfaction
13%
Decisional Satisfaction
13%
Legal Practice
13%
Focused Ultrasound Therapy
13%
Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
13%
Tokophobia
13%
Cardio-obstetrics
13%
Nuchal Translucency
13%
Increased nuchal Translucency
13%
Normal Karyotype
13%
Biopsychosocial Approach
13%
Pregnancy Pathology
13%
Anxiety Symptoms
13%
Social Support
13%
Depressive Symptoms
13%
Anti-D Prophylaxis
13%
D Antigen
13%
Heart Transplantation
13%
Blood Cortisol
10%
Sleep Initiation
10%
Peptide Receptor Radionuclide Therapy
9%
Northern Italy
9%
Labor Anxiety
9%
Sick children
9%
Fetal Diseases
8%
Contentment
6%
Membrane Molecules
6%
Neuroendocrine Neoplasms
6%
Intrapartum Cesarean Section
6%
Endocrine Disrupting Potential
6%
Anxiety Scale
6%
Informational Support
6%
Disrupting Chemicals
6%
Signal Transduction Genes
6%
Follicle Maturation
6%
Pathology Department
6%
Immunoglobulin Prophylaxis
6%
Anti-D Immunoglobulin
6%
Emotional Support
6%
Genetic Family
6%
Population Unique
6%
Inherited Cardiac Conditions
6%
Cardiac Health
6%
Hospital Anxiety
6%
Depression Scale
6%
Intracranial Volume
6%
Summary of Findings Table
6%
Change across the Lifespan
6%
Abnormal Brain Development
6%
Quantitative Biomarkers
6%
Sources of Support
5%
Instrumental Support
5%
Lethal Defects
5%
Nursing and Health Professions
Cross-Sectional Study
31%
Pregnancy Termination
27%
Postnatal Depression
27%
Social Support
27%
Prevalence
24%
Clinical Practice
15%
Medical Procedures
15%
Cardiovascular Disease
13%
Patient with Epilepsy
13%
Patient Satisfaction
13%
Cardiomyopathy
13%
Suburethral Sling
13%
Transobturator Tape Procedure
13%
Patient Care
13%
Physician
13%
Patient-Centered Care
13%
Female Genital Mutilation
13%
Meta Analysis
13%
Systematic Review
13%
Symptom
13%
Rhesus D Antibody
13%
Heart Transplantation
13%
Gestational Weight Gain
10%
Tension Free Vaginal Tape
10%
Hospital Anxiety and Depression Scale
9%
Mood Disorder
5%
